Stock Price Forecast

Aug. 6, 2021


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Intec Parent Inc chart...

About the Company

Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism.

CEO

Jeffrey Meckler

Exchange

NASDAQ CAPITAL MARKET

Website

intecpharma.com

$10M

Total Revenue

40

Employees

$520M

Market Capitalization

-37.04

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $NTEC News

Parents petition to get administrators at an IPS school removed

2d ago, source: cbs4indy

Local parents are petitioning to remove administrators at George Washington Carver Montessori School 87. The online petition ...

Indaptus Therapeutics Presents Positive Mechanism of Action Data at the American Association for Cancer Research Annual Meeting

12d ago, source: Business Insider

NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a clinical stage biotechnology ... except as required by applicable law. Intec Parent NewsMORE Related Stocks ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...